Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-29

Clinical Trial Update: PK and Safety of SI-722 in IC/BPS [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports on pharmacokinetics and safety of SI-722 in Interstitial Cystitis and Bladder Pain Syndrome across Phase 1 and Phase 2, with com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SI-722 (SI-722)

Snippet

Sponsor: Seikagaku Corporation | Conditions: Interstitial Cystitis, Bladder Pain Syndrome | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-12-29